Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease
- PMID: 11085894
- DOI: 10.1006/exnr.2000.7514
Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease
Abstract
Functional imaging by repeated noninvasive scans of specific (18)F tracer distribution using a high-resolution small-animal PET scanner, the microPET, assessed the time course of alterations in energy utilization and dopamine receptors in rats with unilateral striatal quinolinic acid lesions. Energy utilization ipsilateral to the lesion, determined using scans of 2-deoxy-2-[(18)F]fluoro-d-glucose uptake, was compromised severely 1 week after intrastriatal excitotoxin injections. When the same rats were imaged 5 and 7 weeks postlesion, decrements in energy metabolism were even more prominent. In contrast, lesion-induced effects on dopamine D(2) receptor binding were more progressive, with an initial upregulation of [3-(2'-(18)F]fluoroethyl)spiperone binding apparent 1 week postlesion followed by a decline 5 and 7 weeks thereafter. Additional experiments revealed that marked upregulation of dopamine D(2) receptors consequent to quinolinic acid injections could be detected as early as 3 days after the initial insult. Postmortem markers of striatal GABAergic neurons were assessed in the same rats 7 weeks after the lesion: expression of glutamic acid decarboxylase and dopamine D(1) receptor mRNA, as well as [(3)H]SCH-23,390 and [(3)H]spiperone binding to dopamine D(1) and D(2) receptors, respectively, detected prominent decrements consequent to the lesion. In contrast, by 7 weeks postlesion [(3)H]WIN-35,428 binding to dopamine transport sites within the striatum appeared to be enhanced proximal to the quinolinic acid injection sites. The results demonstrate that functional imaging using the microPET is a useful technique to explore not only the progressive neurodegeneration that occurs in response to excitotoxic insults, but also to examine more closely the intricacies of neurotransmitter activity in a small animal model of HD.
Copyright 2000 Academic Press.
Similar articles
-
Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.Neuroscience. 2000;95(2):377-88. doi: 10.1016/s0306-4522(99)00457-1. Neuroscience. 2000. PMID: 10658617
-
Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.J Neural Transm (Vienna). 2000;107(8-9):873-84. doi: 10.1007/s007020070039. J Neural Transm (Vienna). 2000. PMID: 11041269
-
Adenosine A2A receptor imaging with [11C]KF18446 PET in the rat brain after quinolinic acid lesion: comparison with the dopamine receptor imaging.Ann Nucl Med. 2002 Nov;16(7):467-75. doi: 10.1007/BF02988643. Ann Nucl Med. 2002. PMID: 12508837
-
Dysfunctional striatal dopamine signaling in Huntington's disease.J Neurosci Res. 2019 Dec;97(12):1636-1654. doi: 10.1002/jnr.24495. Epub 2019 Jul 15. J Neurosci Res. 2019. PMID: 31304622 Review.
-
The quinolinic acid hypothesis in Huntington's chorea.J Neurol Sci. 1990 Jan;95(1):29-38. doi: 10.1016/0022-510x(90)90114-3. J Neurol Sci. 1990. PMID: 2159984 Review.
Cited by
-
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation.Eur J Nucl Med Mol Imaging. 2008 Apr;35(4):704-15. doi: 10.1007/s00259-007-0651-7. Epub 2007 Dec 15. Eur J Nucl Med Mol Imaging. 2008. PMID: 18080815
-
PET-based molecular imaging in neuroscience.Eur J Nucl Med Mol Imaging. 2003 Jul;30(7):1051-65. doi: 10.1007/s00259-003-1202-5. Epub 2003 May 23. Eur J Nucl Med Mol Imaging. 2003. PMID: 12764552 Review.
-
Effect of caffeic acid and rofecoxib and their combination against intrastriatal quinolinic acid induced oxidative damage, mitochondrial and histological alterations in rats.Inflammopharmacology. 2009 Aug;17(4):211-9. doi: 10.1007/s10787-009-0012-1. Epub 2009 Jul 26. Inflammopharmacology. 2009. PMID: 19633993
-
Huntington's disease.Mol Pathol. 2001 Dec;54(6):409-13. doi: 10.1136/mp.54.6.409. Mol Pathol. 2001. PMID: 11724916 Free PMC article. Review.
-
Animal models of neurodegenerative disease: insights from in vivo imaging studies.Mol Imaging Biol. 2007 Jul-Aug;9(4):186-95. doi: 10.1007/s11307-007-0093-4. Mol Imaging Biol. 2007. PMID: 17357857 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous